Artificial Retina Market Size, Demand & Growth by 2034

Coverage: By Type ( Epiretinal Implants, Subretinal Implants, Suprachoroidal Implants, Others ); End User ( Hospitals, Ophthalmic Clinics, Research Institutes, Others ), and Geography (North America, Europe, Asia Pacific, and South and Central America)

Historic Data: 2021-2024 | Base Year: 2025 | Forecast Period: 2026-2034
  • Status : Data Released
  • Report Code : TIPRE00007598
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
  • Last update date : January 27, 2025
Artificial Retina Market Size, Demand & Growth by 2034
Report Date: January 27, 2025   |   Report Code: TIPRE00007598 Email: sales@theinsightpartners.com

2025 Market Size

US$ 221.57 Mn

Base year value

2034 Forecast

US$ 903.35 Mn

Projected by 2034

CAGR 2026-2034

16.90 %

Growth rate

Addressable Market

US$ 4,715.77 Mn

(2026-2034)

Artificial Retina market is expected to register a CAGR of 16.90% from 2026 to 2034, with the market size expanding from US$ 221.57 Million in 2025 to US$ 903.35 Million by 2034.

The report is segmented by Artificial Retina Market By Type ( Epiretinal Implants, Subretinal Implants, Suprachoroidal Implants, Others ); End User ( Hospitals, Ophthalmic Clinics, Research Institutes, Others ), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.

Purpose of the Report

The report Artificial Retina Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Artificial Retina Market Segmentation

Type

  • Epiretinal Implants
  • Subretinal Implants
  • Suprachoroidal Implants
  • Others

End User

  • Hospitals
  • Ophthalmic Clinics
  • Research Institutes
  • Others

Market Assessment and Insights

  • Global market for Artificial Retina was valued at US$ 221.57 Million in 2025
  • Annual market size is expected to reach US$ 903.35 Million by 2034
  • Total addressable market (TAM) during 2026-2034 is projected to reach approximately US$ 4,715.77 Million
  • Market is anticipated to register a CAGR of 16.9% during the forecast period
  • The United States represents a key market, supported by Rising Prevalence of Retinal Diseases, Investment in Research, Entry of New Market Participants, as well as evolving industry dynamics
  • Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
  • Market opportunities such as IMIE 256, POLYRETINA, PRIMA are expected to influence market dynamics and addressable market
  • Report profiles industry participants, including Aetna Inc., Bionic Vision Australia, BrightFocus Foundation, Kurzweil Network, Nano Retina, Optobionics, Pixium Vision, Retina Consultants of Boston, Retina Implant AG, Second Sight, while analyzing competitive strategies and innovation developments
  • Source: The Insight Partners' analysis based on proprietary research, government publications, company annual reports, investor presentations, industry databases, and expert interviews.

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • Segmentations
  • Geography
  • Competitive Analysis
  • Language Preferences

Artificial Retina Market: Strategic Insights

artificial-retina-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Artificial Retina Market Growth Drivers

  • Rising Prevalence of Retinal Diseases: The market for artificial retinas is significantly driven by the increase in occurrences of retinitis pigmentosa and age-related macular degeneration. Since these illnesses are among the most common causes of vision loss, especially in the elderly, there is an increasing need for efficient therapies.
  • Investment in Research :The governmental and corporate sectors have increased their support for research into artificial retina technologies. This funding is encouraging creativity and hastening the creation of new goods that can enhance visual function. Such a factor has assisted the overall growth in the recent past and is expected to continue a similar trend during the forecast period.
  • Entry of New Market Participants:The market is becoming more competitive and innovative as a result of the emergence of new startups specializing on artificial retina technologies. These businesses are developing cutting-edge methods to increase functionality, decrease size, and improve device compatibility, which may encourage wider adoption.

Artificial Retina Market Future Trends

  • Technological Advancements: Continuous improvements in artificial retina technology, including innovations in electrode design and image processing algorithms, are enhancing the efficacy of these devices. This advancement in technology is essential for creating more practical and user-friendly solutions.Such a factor has assisted the overall market growth in the recent past and is anticipated to continue a similar trend during the forecast period.
  • Rising Government Initiatives: Funding and supportive government initiatives targeted at developing healthcare technology are also driving industry expansion. It is anticipated that increased focus on ophthalmology research would lead to more developments in artificial retina solutions. Such a factor has assisted the overall market growth in the recent past and is anticipated to continue a similar trend during the forecast period.
  • Increased Investment in Research and Development: An emerging trend is an increase in investment in research and development within the artificial retina market. As the technology is continuously being advanced and potentially treating a broader spectrum of vision impairments, pharmaceutical companies, as well as research institutes, are investing in innovation to make the implants work better and integrate with the body more efficiently. The expansion of this market is also accelerating the development of the next generation of retinal implants.

Artificial Retina Market Opportunities

  • IMIE 256: This IMIE 256 device seems to have really great promise for individuals with end-stage retinitis pigmentosa. After a 90-day rehabilitation period, patients exhibited considerable improvement in visual performance, such as that of square localization and motion detection. Certainly, the whole device safety profile has only one adverse event recorded in it, making it quite favorable as far as potential long-term use and enhancement of quality of life for severely visually impaired patients are concerned.
  • POLYRETINA: The POLYRETINA prosthesis employs a very high-density array of photovoltaic pixels, causing stimulation of retinal ganglion cells through an optimal irradiance level. This has led to hailed enhancement in mid-peripheral vision in patients afflicted with retinitis pigmentosa. This improvement manifests in terms of an upscaled spatial resolution as well as visual functionality. This revolutionized concept may reestablish a considerable part of vision lost, especially at the mid-peripheral field, thus providing a great hope in retinal prosthetic technology.
  • PRIMA: The impressive outcomes from a multicenter trial with long-term use for the PRIMA system via its subretinal implants are thus far reaching. After four years, patients enjoyed positive changes in visual acuity, with some patients registering an eight-line improvement on the ETDRS chart. This finding implies that subretinal implants would probably yield better visual resolution than epiretinal devices, offering new possibilities for patients with severe vision impairment owing retinal degenerative diseases.

Artificial Retina Market Report Scope

Report Attribute Details
Market size in 2025 US$ 221.57 Million
Market Size by 2034 US$ 903.35 Million
Global CAGR (2026 - 2034) 16.90%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Type
  • Epiretinal Implants
  • Subretinal Implants
  • Suprachoroidal Implants
  • Others
By End User
  • Hospitals
  • Ophthalmic Clinics
  • Research Institutes
  • Others
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Aetna Inc.
  • Bionic Vision Australia
  • BrightFocus Foundation
  • Kurzweil Network
  • Nano Retina
  • Optobionics
  • Pixium Vision
  • Retina Consultants of Boston
  • Retina Implant AG
  • Second Sight

Artificial Retina Market Players Density: Understanding Its Impact on Business Dynamics

The Artificial Retina Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

artificial-retina-market-cagr

Key Selling Points

  • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Artificial Retina Market, providing a holistic landscape.
  • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Artificial Retina Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


Frequently Asked Questions

In Europe, the UK held the second largest share in 2025.

Hospital segment accounted for the largest share in 2025 and is expected to retain its dominance during the forecast period

North America held the largest share in 2025 and is expected to retain its dominance during the forecast period

The Artificial Retina Market is estimated to witness a CAGR of 16.90% from 2026 to 2034

IMIE 256 - Product Development

Rising prevalence of retinal diseases
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA